Pars Plana Vitrectomy versus Immunomodulatory Therapy for Intermediate Uveitis: A Prospective, Randomized Pilot Study

REFERENCES

• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Boyd SR, Young S, Lightman S. Immunopathology of the Noninfectious Posterior and Intermediate Uveitides. Surv Ophth. 2001;46:209–233.
   PubMed Web of Science ®Google Scholar
• Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin Ophthalmol. 2005;20:147–154.
   PubMedGoogle Scholar
• Zierhut M, Vitale A. Intermediate uveitis. In: Foster CS, Vitale A, eds. Diagnosis and Treatment of Uveitis. Philadelphia, PA: WB Saunders;2001:844–857.
   Google Scholar
• Nolle B, Eckardt C. Cellular phenotype of vitreous cells in intermediate uveitis. Dev Ophthalmol. 1992;23:145–149.
   PubMedGoogle Scholar
• Kaplan HJ. Surgical treatment of intermediate uveitis. Dev Ophthalmol. 1992;23:185–189.
   PubMedGoogle Scholar
• Kanski JJ, Shun-Shin A. Systematic uveitis syndromes in childhood; an analysis of 340 cases. Ophthalmology. 1984;91:1247–1252.
   PubMed Web of Science ®Google Scholar
• Holland GN. The enigma of pars planitis, revisited. Am J Ophthalmol. 2006;141:729–730.
   Google Scholar
• Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096–1105.
   PubMed Web of Science ®Google Scholar
• Stavrou P, Baltatzis S, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflamm. 2001;9:141–151.
   PubMed Web of Science ®Google Scholar
• Harper SL, Chorich III LJ, Foster CS. Diagnosis of uveitis. In: Foster CS, Vitale A, eds. Diagnosis and Treatment of Uveitis. Philadelphia, PA: WB Saunders; 2001:79–103.
   Google Scholar
• Brockhurst RJ, Schepens CL; Uveitis IV. Peripheral uveitis: the complication of retinal detachment. Arch Ophthalmol. 1968;80:747–753.
   PubMedGoogle Scholar
• Lemos SR, Orefice F. Uveite intermediaria. In: Orefice, F. Uveıtes—Clınica e Cirurgica. Rio de Janeiro: Editorial Cultura Medica; 2000;843–859.
   Google Scholar
• Lai WW, Pulido JS. Intermediate uveitis. Ophthalmol Clin N Am. 2002;15:309–317.
   PubMedGoogle Scholar
• Mieler WF, Aaberg TM. Vitreous surgery in the management of peripheral uveitis. Dev Ophthalmol. 1992; 23:239–250.
   PubMedGoogle Scholar
• Heimann K, Schmanke L, Brunner R, Amerian B. Pars plana vitrectomy in the treatment of chronic uveitis. Dev Ophthalmol. 1992; 23:196–203.
   PubMedGoogle Scholar
• Eckardt C, Bacskulin A. Vitrectomy in intermediate uveitis. Dev Ophthalmol. 1992; 23:232–238.
   PubMedGoogle Scholar
• Heiligenhaus A, Bornfeld N, Foerster MH, Wessing A. Long-term results of pars plana vitrectomy in the management of complicated uveitis. Br J Ophthalmol. 1994;78:549–5454.
   PubMed Web of Science ®Google Scholar
• Scott RA, Haynes RJ, Orr GM, Cooling RJ, Pavesio CE, Charteris DG. Vitreous surgery in the management of chronic endogenous posterior uveitis. Eye. 2003;17:221–227.
   PubMed Web of Science ®Google Scholar
• Wiechens B, Reichelt JA, Urbat C, Nolle B. Pars plana vitrectomy in cystoid macular edema of different forms of chronic uveitis. Ophthalmologe. 2003;100:33–43.
   PubMed Web of Science ®Google Scholar
• Potter MJ, Myckatyn SO, Maberley AL, Lee AS. Vitrectomy for pars planitis complicated by vitreous hemorrhage: visual outcome and long-term follow-up. Am J Ophthalmol. 2001;131:514–515.
   PubMedGoogle Scholar
• Dev S, Mieler WF, Pulido JS, Mittra RA. Visual outcomes after pars plana vitrectomy for epiretinal membranes associated with pars planitis. Ophthalmology. 1999;106:1086–1090.
   Google Scholar
• Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol. 1996;7:77–79.
   PubMedGoogle Scholar
• Bacskulin A, Eckardt C. Ergebnisse der pars plana-Vitrektomie. Ophthalmologe. 1993;90:434–439.
   Google Scholar
• Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;96:1798–1804.
   PubMed Web of Science ®Google Scholar
• Trittibach P, Koerner F, Sarra GM, Garweg JG. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome. Eye. 2006;20:184–190.
   PubMedGoogle Scholar
• Bloch ME, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–235.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology. 1996;103:375–383.
   PubMed Web of Science ®Google Scholar
• Wong VG, Hersh EM: Methotrexate in the treatment of cyclitis. Trans Am Acad Arch Ophthalmol Otolaryngol. 1965;69:279–293.
   Google Scholar
• Rubin B, Palestine AG. Complications of corticosteroid and immunosuppressive drugs. Int Ophthalmol Clin. 1989;29:159–171.
   PubMedGoogle Scholar
• Walton RC, Nussenblatt RB, Whitcup SM. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents. Ophthalmology. 1998;105:2028–2034.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC. Cyclosporine therapy for uveitis: long-term followup. J Ocul Pharmacol. 1985;1:369–382.
   PubMedGoogle Scholar
• Schlote T, Dannecker G, Thiel HJ, Zierhut M: Cyclosporin A in der Therapie der chronischen Uveitis im Kindesalter. Ophthalmologe. 1996;93:745–748.
   Google Scholar
• Cimino L, Finzi G, Mora P, Zavota L, Gandolfi SA, Orsoni JG. Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis. Ocul Immunol Inflamm. 2003;11:299–303.
   Web of Science ®Google Scholar
• Greiner K, Varikkara M, Santiago C, Forrester JV. Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis. Ophthalmologe. 2002;99:691–694.
   PubMedGoogle Scholar
• Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest Ophthalmol Vis Sci. 2001;42:1285–1292.
   PubMed Web of Science ®Google Scholar
• Menezo V, Lau C, Comer M, Lightman S. Clinical outcome of chronic immunosuppression in patients with non-infectious uveitis. Clin Exp Ophthalmol. 2005;33:16–21.
   PubMed Web of Science ®Google Scholar